JPRN-jRCT2080220478未知1 期
A Two-Part Study in Japanese Patients With Advanced or Metastatic NSCLC. Open-Label Phase I to Assess the Safety & Tolerability of AZD2171 in Combination With Pac/Carb, Then a Phase II, Randomised, Double-Blind Study to Assess the Efficacy of AZD2171 Alone and in Combination With AZD2171 and Pac/Carb
适应症
试验速览
- 阶段
- 1 期
- 发起方
- AstraZeneca
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Ages Eligible for Study: 18 Years and older
- •Genders Eligible for Study: Both
- •Inclusion Criteria:
- •- Having histologically or cytologically confirmed NSCLC
- •- Patients with previously untreated advanced/metastatic (Stage IIIB/IV) or postsurgery recurrent NSCLC
- •- WHO performance status 0-1
排除标准
- •- Untreated unstable brain or meningeal metastases
- •- Patient with inappropriate laboratory tests values
- •- Patient with poorly controlled hypertension
研究者
相似试验
已完成
2 期
Japanese phase II study in untreated patients with CD20 positive B-cell non-Hodgkin's lymphoma evaluating safety of 90-minute infusion of rituximab.CD20 positive follicular lymphoma or diffuse large B-cell lymphoma.JPRN-jRCT2080223607ZENYAKU KOGYO CO., LTD.33
招募中
不适用
ong-term outcomes of Japanese patients with deferral of coronary intervention based on fractional flow reserve in multicenter registrystable angina pectoris and unstable angina pectorisJPRN-UMIN000014473Physiological PCI Live Demonstration Office1,200
尚未招募
不适用
Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19inflammatory bowel disease COVID-19JPRN-UMIN000040656Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine200
尚未招募
不适用
A Study of Prognosis in Late-Stage Parkinson's Disease in JapaParkinson's diseaseJPRN-UMIN000053949ational Hospital Organization Higashinagoya National Hospital500
已完成
不适用
Observation study for Japanese patients with head and neck cancer by combination therapy with cetuximabsquamous-cell carcinoma of head and neckJPRN-UMIN000011911Japanese Oncology Radiation Study Group300